| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |